BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19638544)

  • 1. Immunophenotype of neoplastic plasma cells in AL amyloidosis.
    Deshmukh M; Elderfield K; Rahemtulla A; Naresh KN
    J Clin Pathol; 2009 Aug; 62(8):724-30. PubMed ID: 19638544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of tumour cell immunophenotype in myeloma and its impact on clinical outcome.
    Ngo NT; Brodie C; Giles C; Horncastle D; Klammer M; Lampert IA; Rahemtulla A; Naresh KN
    J Clin Pathol; 2009 Nov; 62(11):1009-15. PubMed ID: 19861559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Instability of immunophenotype in plasma cell myeloma.
    Cao W; Goolsby CL; Nelson BP; Singhal S; Mehta J; Peterson LC
    Am J Clin Pathol; 2008 Jun; 129(6):926-33. PubMed ID: 18480010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The degrees of plasma cell clonality and marrow infiltration adversely influence the prognosis of AL amyloidosis patients.
    Perfetti V; Colli Vignarelli M; Anesi E; Garini P; Quaglini S; Ascari E; Merlini G
    Haematologica; 1999 Mar; 84(3):218-21. PubMed ID: 10189385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
    Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
    Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six color flow cytometry detects plasma cells expressing aberrant immunophenotype in bone marrow of healthy donors.
    Peceliunas V; Janiulioniene A; Matuzeviciene R; Griskevicius L
    Cytometry B Clin Cytom; 2011 Sep; 80(5):318-23. PubMed ID: 21634008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow trephine combined with immunohistochemistry is superior to bone marrow aspirate in follow-up of myeloma patients.
    Joshi R; Horncastle D; Elderfield K; Lampert I; Rahemtulla A; Naresh KN
    J Clin Pathol; 2008 Feb; 61(2):213-6. PubMed ID: 17526802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma.
    Lin P; Owens R; Tricot G; Wilson CS
    Am J Clin Pathol; 2004 Apr; 121(4):482-8. PubMed ID: 15080299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow core biopsy specimens in AL (primary) amyloidosis. A morphologic and immunohistochemical study of 100 cases.
    Swan N; Skinner M; O'Hara CJ
    Am J Clin Pathol; 2003 Oct; 120(4):610-6. PubMed ID: 14560572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma.
    Liu D; Lin P; Hu Y; Zhou Y; Tang G; Powers L; Medeiros LJ; Jorgensen JL; Wang SA
    J Clin Pathol; 2012 Sep; 65(9):823-9. PubMed ID: 22685235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential therapeutic targets in plasma cell disorders: A flow cytometry study.
    Lisenko K; Schönland S; Hegenbart U; Wallenwein K; Braun U; Mai EK; Hillengass J; Goldschmidt H; Jauch A; Ho AD; Raab M; Hundemer M
    Cytometry B Clin Cytom; 2017 Mar; 92(2):145-152. PubMed ID: 26666746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Close correlations between CD20 expression, a small mature plasma cell morphology and t(11 ; 14) in multiple myeloma].
    Matsuda I; Mori Y; Nakagawa Y; Sawanobori M; Uemura N; Suzuki K
    Rinsho Ketsueki; 2005 Dec; 46(12):1293-7. PubMed ID: 16447802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of plasma cell percentages by CD138 immunohistochemistry, cyclin D1 status, and CD56 expression with clinical parameters and overall survival in plasma cell myeloma.
    Dunphy CH; Nies MK; Gabriel DA
    Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):248-54. PubMed ID: 17721267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.
    Siragusa S; Morice W; Gertz MA; Kyle RA; Greipp PR; Lust JA; Witzig TE; Lacy MQ; Zeldenrust SR; Rajkumar SV; Russell SJ; Hayman SR; Buadi F; Kumar SK; Dingli D; Dispenzieri A
    Ann Hematol; 2011 Jan; 90(1):101-6. PubMed ID: 20645101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
    Martín P; Santón A; Bellas C
    Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotypic analysis of abnormal plasma cell clones in bone marrow of primary systemic light chain amyloidosis patients.
    Hu Y; Wang M; Chen Y; Chen X; Fang F; Liu S; Zhang Y; Wu X; Zhu P
    Chin Med J (Engl); 2014; 127(15):2765-70. PubMed ID: 25146610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 overexpression in multiple myeloma. A morphologic, immunohistochemical, and in situ hybridization study of 71 paraffin-embedded bone marrow biopsy specimens.
    Athanasiou E; Kaloutsi V; Kotoula V; Hytiroglou P; Kostopoulos I; Zervas C; Kalogiannidis P; Fassas A; Christakis JI; Papadimitriou CS
    Am J Clin Pathol; 2001 Oct; 116(4):535-42. PubMed ID: 11601138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.
    Gouvêa AF; Ribeiro AC; León JE; Carlos R; de Almeida OP; Lopes MA
    J Oral Pathol Med; 2012 Feb; 41(2):178-85. PubMed ID: 21883489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodular amyloidoma and primary pulmonary lymphoma with amyloid production: a differential diagnostic problem.
    Dacic S; Colby TV; Yousem SA
    Mod Pathol; 2000 Sep; 13(9):934-40. PubMed ID: 11007032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric immunophenotyping and minimal residual disease analysis in multiple myeloma.
    Gupta R; Bhaskar A; Kumar L; Sharma A; Jain P
    Am J Clin Pathol; 2009 Nov; 132(5):728-32. PubMed ID: 19846814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.